Covid-19/Influenza A+B/RSV Antigen Combo Rapid Test Kit

Introduction

The COVID-19/Influenza A+B/RSV Antigen Combo Rapid Test Kit is an immunochromatographic assay intended for the simultaneous rapid in vitro qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B, RSV antigens in healthcare provider-collected nasal swabs and nasopharyngeal swabs.

Product Details

Product Tags

Principle

The COVID-19/Influenza A+B/RSV Antigen Combo Rapid Test Kit is based on the principle of a qualitative immunochromatographic assay for the determination of SARS-CoV-2, Influenza A/B and RSV from nasal swab and nasopharyngeal swab samples from patients.

Strip ‘COVID-19 Ag/RSV’ consists of a nitrocellulose membrane pre-coated with mouse anti-SARS-CoV-2 antibodies/anti-RSV antibody on the test line (T line) and with goat anti-mouse polyclonal antibodies on the control line (C line). The conjugate pad is sprayed with gold-labeled solution (mouse monoclonal antibodies anti-SARS-CoV-2/ anti-RSV). Strip ‘Flu A+B’ consists of a nitrocellulose membrane pre-coated with mouse anti-Influenza A antibodies on the ‘A’ line, mouse anti-Influenza B antibodies on the ‘B’ line and with goat anti-mouse polyclonal antibodies on the control line (C line). The conjugate pad is sprayed with gold-labeled solution (mouse monoclonal antibodies anti-influenza A and B)

If the sample is SARS-CoV-2/RSV positive, the antigens of the sample react with the gold-labeled anti-SARS-CoV-2 monoclonal antibodies/ anti-RSV antibody in the Strip ‘COVID-19 Ag/RSV’ which was previously pre-dried on the conjugate pad. The mixtures then captured on the membrane by the pre-coated SARS-CoV-2 monoclonal antibodies/RSV antibody and a red line will be visible in the strips indicating a positive result.

If the sample is Influenza A and/or B positive, the antigens of the sample react with the gold-labeled anti-Influenza A and/or monoclonal antibodies in the Strip ‘Flu A+B’, which were previously pre-dried on the conjugate pad. The mixtures then captured on the membrane by the pre-coated Influenza A and/or B monoclonal antibodies and a red line will be visible in their respective lines indicating a positive result.

If the sample is negative, there is no SARS-CoV-2 or RSV or Influenza A or Influenza B antigens presence or the antigens may be present in a concentration below the limit of detection (LoD) for which the the red lines will not appear. Whether the sample is positive or not, in the 3 strips, the C lines will always appear. The presence of these green lines serve as: 1) verification that sufficient volume is added, 2) that proper flow is obtained and 3) an internal control for the kit.

Product Features

Efficiency: 4 in 1 test

Fast results: test results in 15 minutes

Reliable, high performance

Convenient: Simple operation, no equipment required

Simple Storage: Room temperature

Product Specification

Principle Chromatographic immunoassay
Format Cassette
Certificate CE
Specimen Nasal swab / Nasopharyngeal swab
Specification 20T / 40T
Storage temperature 4-30℃
Shelf life 18 months

Ordering Information

Product name Pack Specimen
COVID-19/Influenza A+B/RSV Antigen Combo Rapid Test Kit 20T / 40T Nasal swab / Nasopharyngeal swab


  • Previous:
  • Next:

  • Write your message here and send it to us

    Professional technical engineer dedicated to guide you

    According to your actual needs, choose the most reasonable overall design and planning procedures